TherapeuticsMD, Inc. (TXMD)
NASDAQ: TXMD · IEX Real-Time Price · USD
4.40
+0.25 (6.02%)
At close:
Jun 2, 2023, 4:00 PM
4.25
-0.15 (-3.41%)
After-hours:
Jun 2, 2023, 5:05 PM EDT
TherapeuticsMD Market Cap
TherapeuticsMD has a market cap or net worth of $45.16 million as of June 2, 2023. Its market cap has increased by 142.77% in one year.
Market Cap
45.16M
Enterprise Value
33.71M
1-Year Change
142.77%
Ranking
Category
Stock Price
$4.40
Market Cap Chart
Since March 27, 2012, TherapeuticsMD's market cap has decreased from $210.70M to $45.16M, a decrease of -78.57%. That is a compound annual growth rate of -12.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 1, 2023 | 41.30M | - |
| May 31, 2023 | 41.30M | 0.98% |
| May 30, 2023 | 40.90M | 6.51% |
| May 26, 2023 | 38.40M | 0.52% |
| May 25, 2023 | 38.20M | -11.37% |
| May 24, 2023 | 43.10M | -3.58% |
| May 23, 2023 | 44.70M | 4.20% |
| May 22, 2023 | 42.90M | -0.23% |
| May 19, 2023 | 43.00M | 1.90% |
| May 18, 2023 | 42.20M | 1.20% |
| May 17, 2023 | 41.70M | -4.79% |
| May 16, 2023 | 43.80M | 0.23% |
| May 15, 2023 | 43.70M | 5.05% |
| May 12, 2023 | 41.60M | 9.76% |
| May 11, 2023 | 37.90M | 3.55% |
| May 10, 2023 | 36.60M | 0.55% |
| May 9, 2023 | 36.40M | -0.82% |
| May 8, 2023 | 36.70M | 1.10% |
| May 5, 2023 | 36.30M | -5.22% |
| May 4, 2023 | 38.30M | 5.51% |
| May 3, 2023 | 36.30M | 4.01% |
| May 2, 2023 | 34.90M | 7.72% |
| May 1, 2023 | 32.40M | -3.28% |
| Apr 28, 2023 | 33.50M | -2.62% |
| Apr 27, 2023 | 34.40M | 2.99% |
View and export this data all the way back to 2012.
Start Free Trial.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alkermes plc | 4.81B |
| Ironwood Pharmaceuticals, Inc. | 1.69B |
| ANI Pharmaceuticals, Inc. | 909.42M |
| Organogenesis Holdings Inc. | 476.48M |
| Eagle Pharmaceuticals, Inc. | 271.64M |
| Lifecore Biomedical, Inc. | 248.31M |
| Aquestive Therapeutics, Inc. | 129.18M |
| Alpha Teknova, Inc. | 108.38M |
| Cumberland Pharmaceuticals Inc. | 23.26M |
| Cyclo Therapeutics, Inc. | 18.35M |
| AcelRx Pharmaceuticals, Inc. | 10.88M |
| Guardion Health Sciences, Inc. | 7.82M |
| Adamis Pharmaceuticals Corporation | 5.56M |
| Evoke Pharma, Inc. | 5.55M |
| PainReform Ltd. | 4.93M |
| Petros Pharmaceuticals, Inc. | 4.92M |
| Agile Therapeutics, Inc. | 4.27M |